Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-4,page-paged-4,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.3.0,vc_responsive

CLIENT NEWS

 

 

  • THE LANCET publishes promising data of APEIRON’s APN01 (rhsACE2) to treat COVID-19 in named patient use
    www.apeiron-biologics.com
  • avateramedical GmbH: German medical technology company avateramedical N.V. appoints Ian Read, former Chairman and CEO of Pfizer, to the Board
    www.avateramedical.com
  • Abivax presents first-half 2020 financial results and operations update
    www.abivax.com
  • 4basebio AG signs term sheet for investment in nanoparticle-based gene therapy delivery technology
    www.4basebio.com
  • Verona Pharma plc: Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
    www.veronapharma.com
  • CENTOGENE Opens Walk-In COVID-19 Testing Facility at Düsseldorf Airport
    www.centogene.com
  • Relief partner NeuroRx submits request for Emergency Use Authorization for RLF-100™ (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy
    www.relieftherapeutics.com
  • CENTOGENE AG: EINLADUNG zur Eröffnung des neuen COVID-19-Testzentrums am Flughafen Düsseldorf – 23. September 2020
    www.centogene.com
  • Verona Pharma plc: Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
    www.veronapharma.com
  • MagForce AG Publishes Shareholder Letter
    www.magforce.de